This paper is only available as a PDF. To read, Please Download here.
Abstract
Congestive heart failure in children is unusual as a presenting problem, and the nonspecific
nature of the signs and symptoms in the pediatric population makes recognition difficult.
Congenital heart disease is most common in the infant whereas older children most
commonly develop congestive heart failure due to cardiomyopathy, myocarditis, electrolyte
abnormalities, dysrhythmias, and, more rarely, endocarditis, and rheumatic carditis.
Management focuses upon stabilization of the airway and ventilation while improving
circulatory function. This is achieved by the use of inotropic agents, combined with
attention to the volume and pressure overload, pulmonary problems, dysrhythmias, and
ongoing follow-up.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Barkin R.M. Rosen P. Emergency Pediatrics. CV Mosby, St Louis1986
- New concepts and drugs in the treatment of congestive heart failure.Pediatr Clin North Am. 1984; 31: 1197
- Treatment of congestive heart failure by altering loading conditions of the heart.J Pediatr. 1985; 107: 697
- Treatment of Cardiac Emergencies.CV Mosby, St Louis1985
- New positive inotropic agents in the treatment of congestive heart failure.N Engl J Med. 1986; 314: 290
- New positive inotropic agents in the treatment of congestive heart failure.N Engl J Med. 1986; 314: 349
Article info
Publication history
Accepted:
June 15,
1986
Received:
May 13,
1986
Identification
Copyright
© 1986 Published by Elsevier Inc.
